These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets. Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901). Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer. Li F; Yang Y; Xu Y; Li K; Song L; Xue Y; Dong D Medicine (Baltimore); 2023 Jan; 102(4):e32781. PubMed ID: 36705391 [TBL] [Abstract][Full Text] [Related]
5. Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations. Simbolo M; Barbi S; Fassan M; Mafficini A; Ali G; Vicentini C; Sperandio N; Corbo V; Rusev B; Mastracci L; Grillo F; Pilotto S; Pelosi G; Pelliccioni S; Lawlor RT; Tortora G; Fontanini G; Volante M; Scarpa A; Bria E J Thorac Oncol; 2019 Sep; 14(9):1651-1661. PubMed ID: 31085341 [TBL] [Abstract][Full Text] [Related]
6. YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities. Stewart CA; Diao L; Xi Y; Wang R; Ramkumar K; Serrano AG; Tanimoto A; Rodriguez BL; Morris BB; Shen L; Zhang B; Yang Y; Hamad SH; Cardnell RJ; Duarte A; Sahu M; Novegil VY; Weissman BE; Frumovitz M; Kalhor N; Solis Soto L; da Rocha P; Vokes N; Gibbons DL; Wang J; Heymach JV; Glisson B; Byers LA; Gay CM Clin Cancer Res; 2024 Oct; 30(20):4743-4754. PubMed ID: 39150543 [TBL] [Abstract][Full Text] [Related]
7. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms. Pelosi G; Melocchi V; Dama E; Hofman P; De Luca M; Albini A; Gemelli M; Ricotta R; Papotti M; La Rosa S; Uccella S; Harari S; Sonzogni A; Asiedu MK; Wigle DA; Bianchi F Exp Mol Pathol; 2024 Feb; 135():104882. PubMed ID: 38237798 [TBL] [Abstract][Full Text] [Related]
8. Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma. Zhou Z; Zhu L; Niu X; Shen S; Zhao Y; Zhang J; Ye J; Han-Zhang H; Liu J; Liu C; Lu S Thorac Cancer; 2019 Apr; 10(4):839-847. PubMed ID: 30793508 [TBL] [Abstract][Full Text] [Related]
9. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Walch AK; Zitzelsberger HF; Aubele MM; Mattis AE; Bauchinger M; Candidus S; Präuer HW; Werner M; Höfler H Am J Pathol; 1998 Oct; 153(4):1089-98. PubMed ID: 9777940 [TBL] [Abstract][Full Text] [Related]
10. The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma. Zhuo M; Guan Y; Yang X; Hong L; Wang Y; Li Z; Chen R; Abbas HA; Chang L; Gong Y; Wu N; Zhong J; Chen W; Chen H; Dong Z; Zhu X; Li J; Wang Y; An T; Wu M; Wang Z; Wang J; Roarty EB; Rinsurongkawong W; Lewis J; Roth JA; Swisher SG; Lee JJ; Heymach JV; Wistuba II; Kalhor N; Yang L; Yi X; Futreal PA; Glisson BS; Xia X; Zhang J; Zhao J Clin Cancer Res; 2020 Feb; 26(4):892-901. PubMed ID: 31694833 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations. Rekhtman N; Pietanza CM; Sabari J; Montecalvo J; Wang H; Habeeb O; Kadota K; Adusumilli P; Rudin CM; Ladanyi M; Travis WD; Joubert P Mod Pathol; 2018 Jan; 31(1):111-121. PubMed ID: 28884744 [TBL] [Abstract][Full Text] [Related]
12. Comparison of four DLL3 antibodies performance in high grade neuroendocrine lung tumor samples and cell cultures. Brcic L; Kuchler C; Eidenhammer S; Pabst D; Quehenberger F; Gazdar AF; Popper H Diagn Pathol; 2019 May; 14(1):47. PubMed ID: 31109352 [TBL] [Abstract][Full Text] [Related]
13. DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile. Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; ; Ruland A; Speel EJM; Dingemans AMC Lung Cancer; 2019 Dec; 138():102-108. PubMed ID: 31678831 [TBL] [Abstract][Full Text] [Related]
14. Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung. Miyoshi T; Umemura S; Matsumura Y; Mimaki S; Tada S; Makinoshima H; Ishii G; Udagawa H; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Aokage K; Hishida T; Yoshida J; Nagai K; Goto K; Tsuboi M; Tsuchihara K Clin Cancer Res; 2017 Feb; 23(3):757-765. PubMed ID: 27507618 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC). Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; Stallinga CM; Roemen GM; Speel EJM; Dingemans AC; Lung Cancer; 2019 Apr; 130():179-186. PubMed ID: 30885341 [TBL] [Abstract][Full Text] [Related]
16. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721 [TBL] [Abstract][Full Text] [Related]
17. Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome. Derks JL; Leblay N; Thunnissen E; van Suylen RJ; den Bakker M; Groen HJM; Smit EF; Damhuis R; van den Broek EC; Charbrier A; Foll M; McKay JD; Fernandez-Cuesta L; Speel EM; Dingemans AC; Clin Cancer Res; 2018 Jan; 24(1):33-42. PubMed ID: 29066508 [No Abstract] [Full Text] [Related]
18. Exploring imaging features of molecular subtypes of large cell neuroendocrine carcinoma (LCNEC). Hermans BCM; Sanduleanu S; Derks JL; Woodruff H; Hillen LM; Casale R; Hoesein FM; de Jong E; Berge DMHJT; Speel EJM; Lambin P; Gietema HA; Dingemans AC Lung Cancer; 2020 Oct; 148():94-99. PubMed ID: 32858338 [TBL] [Abstract][Full Text] [Related]
19. Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma. Wang Y; Chen Y; Yang Z; Qian F; Hu M; Lu J; Zhang Y; Zhang W; Wang K; Han B Ann Surg Oncol; 2022 Sep; 29(9):5666-5678. PubMed ID: 35543906 [TBL] [Abstract][Full Text] [Related]
20. Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas. Wang H; Yan L; Zhu Y; Sun W; Yang X; Liu X; Chi K; Huang X; Zhou L; Lin D Hum Pathol; 2023 Dec; 142():81-89. PubMed ID: 37742943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]